Women's Health

Roundup: Mixed Reality Glasses for Remote Wound Diagnosis and More Memories

ProDentim

[ad_1]

Mixed reality glasses used for remote diagnosis of leg and foot ulcers

Mixed reality smart glasses have been developed for the remote assessment of leg and foot injuries of people with diabetes and vascular disease living in remote areas.

University of Adelaide researchers have invented software for a mixed-reality headset that allows city doctors to ‘see through the eyes’ of rural health workers who assess and treat leg and foot ulcers patients in real time.

“The specialist will be able to direct the rural health professional, who is wearing mixed reality glasses, to different aspects of the wound using holographic projections and, in the future, even see what the wound looked like during a previous telehealth appointment for easy comparison,” explained Dr. Zygmunt Szpak of Insight Via Artificial Intelligence, a business partner involved in the development of the smart glasses software.

Backed by A$2.27 million ($1.5 million) from the federal government’s Future of Medical Research Fund, the smart glasses are set to roll out over the next five years. A trial is also planned from 2024 in selected locations in South Australia.


Australian researchers claim to be the first to develop a method to assess exposure to OSA

Researchers from the School of Psychological Science at the University of Western Australia have developed what may be the world’s first algorithm capable of estimating how long a person has had obstructive sleep apnea.

Called OSA-Onset, the algorithm was established using a range of health variables, including body mass index, weight gain, snoring, diabetes, excessive daytime sleepiness, poor mood and biological sex.

“A longer duration of exposure to a risk factor is often linked to poorer health,” said Dr Michelle Olaithe, but until recently there had been no established method to check how long a patient was affected by OSA. “As OSA is linked to – and possibly the cause of – other diseases, having a method to estimate its occurrence could help assess the risk of associated diseases,” she added.

Dr Olaith said OSA-Onset will support future studies to identify people who have had prolonged OSA, examine the effects of its long-term exposure and explain the poor response to treatment.


Bp Omni goes into beta

Best Practice Software has begun beta testing its new cloud-based clinical and practice management solution in New Zealand.

Formerly known as Project Titanium, Bp Omni is designed to streamline and simplify daily operations for healthcare providers.

After six years of R&D, the solution is currently being tested with a physical therapy practice and plans to launch its beta version with five other practices over the next few months, according to a press release.

[ad_2]

webmd-mobihealthnews

alpilean
Back to top button